Massachusetts General Hospital SC-9 is a clinical research site located in Boston, Massachusetts, United States 02114.
Crixeo Clinical Trials Trust Score: 82/100 (GOOD). This profile has not yet been claimed by the site owner.
Massachusetts General Hospital SC-9 has participated in 2 clinical trials.
Therapeutic areas: Early Breast Cancer, Advanced Solid Tumor.
Sponsors: Novartis Pharmaceuticals.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Massachusetts · View every site in Boston
Trust Score: 82/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Massachusetts General Hospital SC-9 has a Crixeo Trust Score of 82/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Massachusetts General Hospital SC-9 has 2 clinical trials on record. Their work covers Early Breast Cancer, Advanced Solid Tumor.
Massachusetts General Hospital SC-9 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.